25 XP   0   0   10

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Buy, Hold or Sell?

Let's analyse Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd together

PenkeI guess you are interested in Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

I send you an email if I find something interesting about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

Quick analysis of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (30 sec.)










What can you expect buying and holding a share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.13
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥22.56
Expected worth in 1 year
¥24.43
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥2.84
Return On Investment
9.9%

For what price can you sell your share?

Current Price per Share
¥28.65
Expected price per share
¥24.85 - ¥30.30
How sure are you?
50%

1. Valuation of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥28.65

Intrinsic Value Per Share

¥32.96 - ¥121.69

Total Value Per Share

¥55.52 - ¥144.25

2. Growth of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (5 min.)




Is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$5b$4.6b$357.8m7.2%

How much money is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$140.3m$137.2m$3m2.2%
Net Profit Margin5.2%5.4%--

How much money comes from the company's main activities?

3. Financial Health of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (5 min.)




What can you expect buying and holding a share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd? (5 min.)

Welcome investor! Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's management wants to use your money to grow the business. In return you get a share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

What can you expect buying and holding a share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?

First you should know what it really means to hold a share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is ¥28.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥22.56. Based on the TTM, the Book Value Change Per Share is ¥0.47 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.36 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.24 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.090.3%0.080.3%0.080.3%0.060.2%
Usd Book Value Change Per Share0.030.1%0.060.2%0.050.2%0.060.2%0.060.2%
Usd Dividend Per Share0.010.0%0.030.1%0.030.1%0.030.1%0.020.1%
Usd Total Gains Per Share0.040.1%0.100.3%0.080.3%0.080.3%0.090.3%
Usd Price Per Share3.96-4.32-4.11-4.45-4.24-
Price to Earnings Ratio43.96-19.60-14.99-42.25-246.68-
Price-to-Total Gains Ratio112.03-59.17--48.04--3.24-79.76-
Price to Book Ratio1.27-1.41-1.44-1.75-2.62-
Price-to-Total Gains Ratio112.03-59.17--48.04--3.24-79.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.96516
Number of shares252
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.03
Usd Book Value Change Per Share0.060.06
Usd Total Gains Per Share0.100.08
Gains per Quarter (252 shares)24.8121.24
Gains per Year (252 shares)99.2284.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1346589285775
26813018856114160
310219628784171245
4136261386112228330
5170326485140285415
6204391584168342500
7238456683196399585
8272522782224456670
9306587881252513755
10340652980280570840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%67.00.01.098.5%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%31.09.00.077.5%55.012.01.080.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%67.00.01.098.5%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%36.04.00.090.0%63.05.00.092.6%

Fundamentals of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern Medicine, Great Commerce, Great Health, and Great Medical Care. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, and medical devices; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, Guiling jellies, etc. In addition, the company invests in health industry, such as medical services, health management, health care, elderly care, etc.; and provides business and advertising agency services. It operates retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-03-26 16:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 1.5% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 1.5%. The company is making a profit. +1
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM5.2%-3.6%
TTM5.2%YOY5.4%-0.2%
TTM5.2%5Y5.0%+0.1%
5Y5.0%10Y6.6%-1.5%
1.1.2. Return on Assets

Shows how efficient Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.3% Return on Assets means that Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM1.4%-1.0%
TTM1.4%YOY1.4%-0.1%
TTM1.4%5Y1.4%0.0%
5Y1.4%10Y1.7%-0.3%
1.1.3. Return on Equity

Shows how efficient Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Equity means Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM3.0%-2.2%
TTM3.0%YOY3.2%-0.2%
TTM3.0%5Y3.1%-0.2%
5Y3.1%10Y3.4%-0.3%

1.2. Operating Efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is operating .

  • Measures how much profit Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.9%-3.9%
TTM3.9%YOY5.4%-1.5%
TTM3.9%5Y5.3%-1.4%
5Y5.3%10Y3.0%+2.3%
1.2.2. Operating Ratio

Measures how efficient Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.84 means that the operating costs are ¥1.84 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 1.837. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.753. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.837TTM1.753+0.084
TTM1.753YOY1.754-0.001
TTM1.7535Y1.756-0.003
5Y1.75610Y1.279+0.477

1.3. Liquidity of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.55 means the company has ¥1.55 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 1.545. The company is able to pay all its short-term debts. +1
  • The TTM is 1.620. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.545TTM1.620-0.075
TTM1.620YOY1.650-0.030
TTM1.6205Y1.635-0.016
5Y1.63510Y0.940+0.695
1.3.2. Quick Ratio

Measures if Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.42 means the company can pay off ¥0.42 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 0.417. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.568. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.568-0.151
TTM0.568YOY0.610-0.042
TTM0.5685Y0.579-0.011
5Y0.57910Y0.526+0.052

1.4. Solvency of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd assets are financed with 53.3% credit (debt) and the remaining percentage (100% - 53.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 0.533. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.520. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.533TTM0.520+0.013
TTM0.520YOY0.518+0.002
TTM0.5205Y0.522-0.002
5Y0.52210Y0.471+0.051
1.4.2. Debt to Equity Ratio

Measures if Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 120.0% means that company has ¥1.20 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The MRQ is 1.200. The company is able to pay all its debts with equity. +1
  • The TTM is 1.138. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.200TTM1.138+0.062
TTM1.138YOY1.155-0.017
TTM1.1385Y1.170-0.032
5Y1.17010Y0.978+0.192

2. Market Valuation of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 43.96 means the investor is paying ¥43.96 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The EOD is 44.037. Based on the earnings, the company is overpriced. -1
  • The MRQ is 43.960. Based on the earnings, the company is overpriced. -1
  • The TTM is 19.598. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD44.037MRQ43.960+0.077
MRQ43.960TTM19.598+24.363
TTM19.598YOY14.990+4.607
TTM19.5985Y42.245-22.648
5Y42.24510Y246.684-204.439
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The EOD is 4.264. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.257. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.595. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.264MRQ4.257+0.007
MRQ4.257TTM4.595-0.338
TTM4.595YOY14.217-9.622
TTM4.5955Y6.724-2.129
5Y6.72410Y16.360-9.636
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

  • The EOD is 1.270. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.268. Based on the equity, the company is underpriced. +1
  • The TTM is 1.412. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.270MRQ1.268+0.002
MRQ1.268TTM1.412-0.144
TTM1.412YOY1.445-0.033
TTM1.4125Y1.747-0.335
5Y1.74710Y2.625-0.878
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1860.467-60%0.355-48%0.409-55%0.439-58%
Book Value Per Share--22.56022.148+2%20.557+10%18.838+20%14.263+58%
Current Ratio--1.5451.620-5%1.650-6%1.635-6%0.940+64%
Debt To Asset Ratio--0.5330.520+3%0.518+3%0.522+2%0.471+13%
Debt To Equity Ratio--1.2001.138+5%1.155+4%1.170+3%0.978+23%
Dividend Per Share--0.0700.244-71%0.204-66%0.201-65%0.179-61%
Eps--0.1630.624-74%0.610-73%0.550-70%0.438-63%
Free Cash Flow Per Share--1.6800.381+341%0.863+95%0.456+268%0.642+162%
Free Cash Flow To Equity Per Share--1.6800.484+247%0.611+175%0.407+313%0.829+103%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--121.690--------
Intrinsic Value_10Y_min--32.964--------
Intrinsic Value_1Y_max--3.967--------
Intrinsic Value_1Y_min--2.707--------
Intrinsic Value_3Y_max--18.189--------
Intrinsic Value_3Y_min--8.699--------
Intrinsic Value_5Y_max--39.971--------
Intrinsic Value_5Y_min--15.263--------
Market Cap40278749875.200-15%46497621141.40050797838201.505-8%48245346411.575-4%52159822195.065-11%47178438183.278-1%
Net Profit Margin--0.0150.052-70%0.054-72%0.050-70%0.066-77%
Operating Margin---0.039-100%0.054-100%0.053-100%0.030-100%
Operating Ratio--1.8371.753+5%1.754+5%1.756+5%1.279+44%
Pb Ratio1.270+0%1.2681.412-10%1.445-12%1.747-27%2.625-52%
Pe Ratio44.037+0%43.96019.598+124%14.990+193%42.245+4%246.684-82%
Price Per Share28.650+0%28.60031.245-8%29.675-4%32.144-11%30.666-7%
Price To Free Cash Flow Ratio4.264+0%4.2574.595-7%14.217-70%6.724-37%16.360-74%
Price To Total Gains Ratio112.226+0%112.03059.175+89%-48.036+143%-3.240+103%79.763+40%
Quick Ratio--0.4170.568-27%0.610-32%0.579-28%0.526-21%
Return On Assets--0.0030.014-75%0.014-77%0.014-76%0.017-80%
Return On Equity--0.0080.030-75%0.032-76%0.031-76%0.034-78%
Total Gains Per Share--0.2550.711-64%0.559-54%0.609-58%0.618-59%
Usd Book Value--5076210828.7014983429620.214+2%4625603633.702+10%4233148964.960+20%3089847377.838+64%
Usd Book Value Change Per Share--0.0260.065-60%0.049-48%0.057-55%0.061-58%
Usd Book Value Per Share--3.1223.065+2%2.845+10%2.607+20%1.974+58%
Usd Dividend Per Share--0.0100.034-71%0.028-66%0.028-65%0.025-61%
Usd Eps--0.0230.086-74%0.084-73%0.076-70%0.061-63%
Usd Free Cash Flow--377933992.54085641162.238+341%194286008.790+95%102694173.344+268%133651545.140+183%
Usd Free Cash Flow Per Share--0.2320.053+341%0.120+95%0.063+268%0.089+162%
Usd Free Cash Flow To Equity Per Share--0.2320.067+247%0.085+175%0.056+313%0.115+103%
Usd Market Cap5574578982.728-15%6435270765.9707030420807.088-8%6677155943.362-4%7218919391.797-11%6529495844.566-1%
Usd Price Per Share3.965+0%3.9584.324-8%4.107-4%4.449-11%4.244-7%
Usd Profit--36596904.617140326482.726-74%137241668.761-73%123495758.014-70%94630105.855-61%
Usd Revenue--2398590259.8602612832978.219-8%2449270165.368-2%2366246193.195+1%1602290405.922+50%
Usd Total Gains Per Share--0.0350.098-64%0.077-54%0.084-58%0.086-59%
 EOD+2 -6MRQTTM+12 -23YOY+12 -235Y+13 -2210Y+15 -20

3.2. Fundamental Score

Let's check the fundamental score of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.037
Price to Book Ratio (EOD)Between0-11.270
Net Profit Margin (MRQ)Greater than00.015
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.417
Current Ratio (MRQ)Greater than11.545
Debt to Asset Ratio (MRQ)Less than10.533
Debt to Equity Ratio (MRQ)Less than11.200
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.003
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.469
Ma 20Greater thanMa 5029.487
Ma 50Greater thanMa 10028.852
Ma 100Greater thanMa 20029.068
OpenGreater thanClose28.540
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  10,63024,62235,252-34,2201,0326,5297,561-31,844-24,283



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets78,586,878
Total Liabilities41,909,054
Total Stockholder Equity34,919,281
 As reported
Total Liabilities 41,909,054
Total Stockholder Equity+ 34,919,281
Total Assets = 78,586,878

Assets

Total Assets78,586,878
Total Current Assets55,983,714
Long-term Assets22,603,164
Total Current Assets
Cash And Cash Equivalents 21,308,844
Short-term Investments 4,000
Net Receivables 15,112,495
Inventory 11,507,100
Other Current Assets 1,869,224
Total Current Assets  (as reported)55,983,714
Total Current Assets  (calculated)49,801,663
+/- 6,182,051
Long-term Assets
Property Plant Equipment 7,513,872
Goodwill 829,473
Intangible Assets 3,196,307
Long-term Assets Other 86,446
Long-term Assets  (as reported)22,603,164
Long-term Assets  (calculated)11,626,098
+/- 10,977,066

Liabilities & Shareholders' Equity

Total Current Liabilities36,235,291
Long-term Liabilities5,673,763
Total Stockholder Equity34,919,281
Total Current Liabilities
Short Long Term Debt 7,799,036
Accounts payable 15,685,868
Other Current Liabilities 695,880
Total Current Liabilities  (as reported)36,235,291
Total Current Liabilities  (calculated)24,180,784
+/- 12,054,507
Long-term Liabilities
Long term Debt 3,323,718
Capital Lease Obligations Min Short Term Debt578,192
Long-term Liabilities Other 130,601
Long-term Liabilities  (as reported)5,673,763
Long-term Liabilities  (calculated)4,032,511
+/- 1,641,252
Total Stockholder Equity
Retained Earnings 20,959,331
Total Stockholder Equity (as reported)34,919,281
Total Stockholder Equity (calculated)20,959,331
+/- 13,959,950
Other
Capital Stock1,625,791
Common Stock Shares Outstanding 1,625,791
Net Invested Capital 46,042,035
Net Working Capital 19,748,423
Property Plant and Equipment Gross 7,513,872



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-06-302005-06-302004-12-312004-06-302003-12-312003-06-302002-12-312002-06-302001-12-31
> Total Assets 
3,697,238
3,899,073
4,173,194
4,460,611
4,954,091
5,135,500
5,413,438
5,575,397
5,689,713
5,640,964
0
6,134,317
6,149,961
6,206,944
5,327,290
5,417,797
4,162,410
4,130,904
4,158,372
4,403,996
4,197,079
4,222,496
4,391,623
4,521,724
4,532,087
4,476,592
4,806,731
4,873,779
4,832,365
4,851,266
5,280,606
5,769,017
6,350,248
6,235,394
7,533,447
11,935,976
11,924,651
12,249,123
13,020,371
13,799,090
14,249,339
14,210,784
14,913,450
16,490,770
15,822,164
15,870,577
16,955,003
17,812,149
25,448,875
25,897,170
26,579,719
26,703,113
27,025,106
28,314,713
28,837,123
48,191,445
49,593,828
51,482,184
51,800,877
53,353,846
54,317,672
56,893,659
56,595,905
55,106,463
58,049,001
59,760,063
62,824,652
62,598,928
64,588,474
66,117,790
67,042,055
66,800,574
69,552,608
74,665,299
73,658,300
73,607,239
74,353,331
78,586,878
78,586,87874,353,33173,607,23973,658,30074,665,29969,552,60866,800,57467,042,05566,117,79064,588,47462,598,92862,824,65259,760,06358,049,00155,106,46356,595,90556,893,65954,317,67253,353,84651,800,87751,482,18449,593,82848,191,44528,837,12328,314,71327,025,10626,703,11326,579,71925,897,17025,448,87517,812,14916,955,00315,870,57715,822,16416,490,77014,913,45014,210,78414,249,33913,799,09013,020,37112,249,12311,924,65111,935,9767,533,4476,235,3946,350,2485,769,0175,280,6064,851,2664,832,3654,873,7794,806,7314,476,5924,532,0874,521,7244,391,6234,222,4964,197,0794,403,9964,158,3724,130,9044,162,4105,417,7975,327,2906,206,9446,149,9616,134,31705,640,9645,689,7135,575,3975,413,4385,135,5004,954,0914,460,6114,173,1943,899,0733,697,238
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,680,181
41,194,602
43,031,286
42,550,209
42,651,181
43,498,252
45,982,233
45,625,886
43,967,720
46,241,429
47,396,618
50,313,913
49,929,853
51,646,661
52,810,574
53,344,072
52,489,254
52,858,434
57,064,312
55,437,164
53,820,159
52,924,980
55,983,714
55,983,71452,924,98053,820,15955,437,16457,064,31252,858,43452,489,25453,344,07252,810,57451,646,66149,929,85350,313,91347,396,61846,241,42943,967,72045,625,88645,982,23343,498,25242,651,18142,550,20943,031,28641,194,60239,680,1810000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,487,135
15,615,786
16,114,884
14,810,934
16,149,475
16,084,694
18,469,618
18,041,385
18,485,644
19,477,778
19,470,276
21,690,807
22,092,141
23,952,122
22,376,928
23,574,034
22,548,729
21,672,994
22,499,553
20,245,925
20,885,971
19,873,967
21,308,844
21,308,84419,873,96720,885,97120,245,92522,499,55321,672,99422,548,72923,574,03422,376,92823,952,12222,092,14121,690,80719,470,27619,477,77818,485,64418,041,38518,469,61816,084,69416,149,47514,810,93416,114,88415,615,78614,487,1350000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,512,000
0
1,542,035
0
11,865
0
0
0
0
0
4,000
4,000
20,000
4,000
0
10,000
50,669
50,669
56,873
56,873
56,873
56,873
4,000
4,00056,87356,87356,87356,87350,66950,66910,00004,00020,0004,0004,0000000011,86501,542,03501,512,0000000000000000000000000000000000000000000000000000000000
       Net Receivables 
684,016
938,008
851,491
1,252,351
1,289,775
1,610,099
1,518,633
1,867,190
2,161,230
2,004,026
0
2,475,277
2,471,223
2,230,533
1,901,571
1,910,554
823,379
811,984
899,128
856,113
693,501
551,322
692,969
713,603
711,698
558,225
845,170
750,917
940,740
904,818
1,249,053
1,192,598
1,225,218
1,082,367
1,495,820
2,219,810
2,002,653
2,416,334
2,971,456
2,810,258
2,524,151
2,610,359
3,331,082
3,448,245
2,988,789
2,636,800
3,207,062
3,434,328
2,680,237
2,887,365
3,452,107
3,307,206
2,977,451
3,493,846
4,469,916
15,572,952
15,214,443
14,457,562
12,667,031
13,339,878
14,645,626
16,770,380
17,491,514
15,618,936
16,441,401
16,455,162
18,897,833
18,517,292
17,898,387
18,486,242
19,858,706
19,469,115
20,005,385
20,088,220
23,040,921
21,266,053
16,521,847
15,112,495
15,112,49516,521,84721,266,05323,040,92120,088,22020,005,38519,469,11519,858,70618,486,24217,898,38718,517,29218,897,83316,455,16216,441,40115,618,93617,491,51416,770,38014,645,62613,339,87812,667,03114,457,56215,214,44315,572,9524,469,9163,493,8462,977,4513,307,2063,452,1072,887,3652,680,2373,434,3283,207,0622,636,8002,988,7893,448,2453,331,0822,610,3592,524,1512,810,2582,971,4562,416,3342,002,6532,219,8101,495,8201,082,3671,225,2181,192,5981,249,053904,818940,740750,917845,170558,225711,698713,603692,969551,322693,501856,113899,128811,984823,3791,910,5541,901,5712,230,5332,471,2232,475,27702,004,0262,161,2301,867,1901,518,6331,610,0991,289,7751,252,351851,491938,008684,016
       Other Current Assets 
122,932
125,259
166,115
87,602
0
18,840
18,562
1,880,300
1,951
0
0
205,350
142,316
166,243
156,426
98,675
104,518
56,843
55,948
0
89,279
97,450
86,787
94,392
134,602
127,327
193,907
197,846
88,654
148,646
200,960
255,271
524,355
436,428
531,226
459,396
651,726
691,990
778,668
680,887
585,144
508,267
434,020
647,034
809,763
494,091
362,297
283,723
234,917
671,956
435,014
527,522
2,191,805
746,069
1,974,507
1,098,897
2,784,554
1,685,066
1,796,750
382,467
282,132
1,210,699
1,352,424
1,157,154
1,150,109
1,652,648
1,389,923
1,139,059
1,216,147
1,509,670
1,170,204
2,228,948
2,689,601
1,631,080
3,148,342
1,204,892
1,311,824
1,869,224
1,869,2241,311,8241,204,8923,148,3421,631,0802,689,6012,228,9481,170,2041,509,6701,216,1471,139,0591,389,9231,652,6481,150,1091,157,1541,352,4241,210,699282,132382,4671,796,7501,685,0662,784,5541,098,8971,974,507746,0692,191,805527,522435,014671,956234,917283,723362,297494,091809,763647,034434,020508,267585,144680,887778,668691,990651,726459,396531,226436,428524,355255,271200,960148,64688,654197,846193,907127,327134,60294,39286,78797,45089,279055,94856,843104,51898,675156,426166,243142,316205,350001,9511,880,30018,56218,840087,602166,115125,259122,932
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,250,668
10,702,665
10,819,420
10,911,426
10,970,019
11,138,743
11,807,572
12,363,445
12,510,739
12,669,075
12,941,813
13,307,215
13,697,983
14,311,320
16,694,174
17,600,987
18,221,136
19,787,080
21,428,350
22,603,164
22,603,16421,428,35019,787,08018,221,13617,600,98716,694,17414,311,32013,697,98313,307,21512,941,81312,669,07512,510,73912,363,44511,807,57211,138,74310,970,01910,911,42610,819,42010,702,6659,250,6680000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
882,194
919,293
1,012,325
1,090,937
1,529,134
1,599,149
1,589,355
1,670,665
1,524,251
1,478,262
0
1,248,487
1,262,419
1,333,918
1,278,546
1,315,089
1,201,200
1,202,397
1,190,590
1,264,286
1,175,260
1,133,533
1,118,912
1,090,084
1,087,159
1,067,537
1,048,823
1,043,471
1,029,091
1,020,391
1,003,231
990,991
983,021
980,137
971,562
1,878,309
1,903,877
2,067,305
2,150,687
2,190,909
2,238,530
2,265,961
2,289,052
2,310,709
2,354,899
2,489,808
2,498,534
2,460,309
2,346,678
2,362,386
2,336,017
2,312,521
2,324,807
2,366,917
2,348,695
3,265,027
3,542,240
3,646,052
4,325,826
4,418,480
4,448,079
4,436,568
4,506,125
4,624,347
4,791,011
5,101,257
5,202,541
5,272,371
5,460,299
5,684,327
5,766,100
5,936,742
6,043,160
6,567,669
6,622,405
6,767,771
7,027,036
7,513,872
7,513,8727,027,0366,767,7716,622,4056,567,6696,043,1605,936,7425,766,1005,684,3275,460,2995,272,3715,202,5415,101,2574,791,0114,624,3474,506,1254,436,5684,448,0794,418,4804,325,8263,646,0523,542,2403,265,0272,348,6952,366,9172,324,8072,312,5212,336,0172,362,3862,346,6782,460,3092,498,5342,489,8082,354,8992,310,7092,289,0522,265,9612,238,5302,190,9092,150,6872,067,3051,903,8771,878,309971,562980,137983,021990,9911,003,2311,020,3911,029,0911,043,4711,048,8231,067,5371,087,1591,090,0841,118,9121,133,5331,175,2601,264,2861,190,5901,202,3971,201,2001,315,0891,278,5461,333,9181,262,4191,248,48701,478,2621,524,2511,670,6651,589,3551,599,1491,529,1341,090,9371,012,325919,293882,194
       Goodwill 
0
0
0
0
0
0
2,004
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,287
2,283
2,283
2,283
2,283
11,500
11,500
11,500
11,500
11,500
11,500
11,500
11,500
943,849
943,849
825,573
825,573
825,573
825,573
825,573
825,573
825,573
825,573
825,573
825,573
825,573
825,573
829,473
829,473
829,473
829,473
829,473
829,473
829,473
829,473
829,473
829,473829,473829,473829,473829,473829,473829,473829,473829,473825,573825,573825,573825,573825,573825,573825,573825,573825,573825,573825,573825,573943,849943,84911,50011,50011,50011,50011,50011,50011,50011,5002,2832,2832,2832,2832,287000000000000000000000000000000000002,004000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,533,985
2,135,903
2,071,794
2,154,580
2,126,726
2,179,062
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,179,0622,126,7262,154,5802,071,7942,135,9032,533,9850000000000000000000000000000000000000000000000000000000
       Intangible Assets 
102,138
102,045
93,768
104,529
61,483
61,045
57,546
49,588
43,953
33,311
0
130,809
129,625
135,704
122,723
121,199
98,468
103,928
103,070
107,833
101,539
99,710
98,759
98,023
97,137
96,963
96,120
95,638
94,753
95,138
94,271
93,726
92,638
92,449
91,741
478,440
477,102
368,857
366,279
385,637
384,105
395,202
395,610
393,021
466,606
542,458
540,253
545,919
654,759
679,805
712,155
737,743
733,137
739,509
735,076
988,081
991,889
1,013,353
1,052,589
1,783,413
2,410,530
2,487,300
2,474,521
2,460,976
2,455,637
2,450,324
2,438,463
2,433,633
2,433,173
2,592,958
2,582,412
2,574,891
2,562,353
2,825,766
2,822,483
2,885,727
2,885,873
3,196,307
3,196,3072,885,8732,885,7272,822,4832,825,7662,562,3532,574,8912,582,4122,592,9582,433,1732,433,6332,438,4632,450,3242,455,6372,460,9762,474,5212,487,3002,410,5301,783,4131,052,5891,013,353991,889988,081735,076739,509733,137737,743712,155679,805654,759545,919540,253542,458466,606393,021395,610395,202384,105385,637366,279368,857477,102478,44091,74192,44992,63893,72694,27195,13894,75395,63896,12096,96397,13798,02398,75999,710101,539107,833103,070103,92898,468121,199122,723135,704129,625130,809033,31143,95349,58857,54661,04561,483104,52993,768102,045102,138
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
242,628
237,764
37,970
289,536
283,222
289,584
747,108
664,499
670,188
801,528
818,182
799,193
218,014
215,970
220,373
239,830
228,129
458,043
450,326
86,446
86,446450,326458,043228,129239,830220,373215,970218,014799,193818,182801,528670,188664,499747,108289,584283,222289,53637,970237,764242,6280000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,413,543
1,499,022
1,750,341
1,907,663
2,220,047
2,387,823
2,655,559
2,729,940
2,696,227
2,560,584
0
3,081,680
3,045,512
2,912,734
2,027,798
2,174,031
954,389
905,993
896,280
954,238
853,786
820,921
920,487
990,889
933,822
835,052
1,075,025
1,091,200
988,775
956,094
1,257,521
1,735,648
2,238,923
2,011,073
3,158,413
5,232,255
5,072,684
5,226,886
5,652,040
6,364,067
6,636,751
6,251,805
6,581,359
8,141,340
7,474,100
7,186,644
7,847,787
8,219,200
7,752,395
8,243,380
8,416,708
8,291,038
8,285,809
9,051,560
8,647,535
26,092,671
26,449,590
28,338,451
27,080,869
28,113,413
28,399,118
30,904,172
29,354,889
28,203,838
30,239,340
31,554,796
32,937,017
32,640,172
33,779,579
34,791,121
33,829,740
33,841,777
35,673,612
41,027,441
38,057,349
38,232,203
37,977,385
41,909,054
41,909,05437,977,38538,232,20338,057,34941,027,44135,673,61233,841,77733,829,74034,791,12133,779,57932,640,17232,937,01731,554,79630,239,34028,203,83829,354,88930,904,17228,399,11828,113,41327,080,86928,338,45126,449,59026,092,6718,647,5359,051,5608,285,8098,291,0388,416,7088,243,3807,752,3958,219,2007,847,7877,186,6447,474,1008,141,3406,581,3596,251,8056,636,7516,364,0675,652,0405,226,8865,072,6845,232,2553,158,4132,011,0732,238,9231,735,6481,257,521956,094988,7751,091,2001,075,025835,052933,822990,889920,487820,921853,786954,238896,280905,993954,3892,174,0312,027,7982,912,7343,045,5123,081,68002,560,5842,696,2272,729,9402,655,5592,387,8232,220,0471,907,6631,750,3411,499,0221,413,543
   > Total Current Liabilities 
1,389,689
1,447,495
1,629,148
1,771,605
2,010,183
2,166,988
2,450,033
2,582,125
2,610,960
2,468,576
0
2,969,843
2,934,828
2,787,960
1,908,185
2,057,258
815,706
751,411
746,463
855,931
738,299
712,021
814,970
886,046
820,894
714,127
963,991
988,124
892,799
871,341
1,171,638
1,651,385
2,152,377
1,915,391
3,065,202
5,069,635
4,901,385
5,050,078
5,480,867
6,178,791
6,416,330
6,061,527
6,391,683
7,895,950
7,131,520
6,828,500
6,994,286
7,356,229
6,928,341
7,422,448
7,603,937
7,507,954
7,476,175
8,268,854
7,858,562
24,345,886
24,680,208
26,948,764
25,249,412
26,551,568
26,896,056
29,376,966
27,821,690
26,590,712
28,198,465
29,243,232
30,613,249
30,059,548
31,220,464
32,253,851
31,191,427
30,677,951
31,987,021
37,395,116
32,888,971
33,049,270
32,688,724
36,235,291
36,235,29132,688,72433,049,27032,888,97137,395,11631,987,02130,677,95131,191,42732,253,85131,220,46430,059,54830,613,24929,243,23228,198,46526,590,71227,821,69029,376,96626,896,05626,551,56825,249,41226,948,76424,680,20824,345,8867,858,5628,268,8547,476,1757,507,9547,603,9377,422,4486,928,3417,356,2296,994,2866,828,5007,131,5207,895,9506,391,6836,061,5276,416,3306,178,7915,480,8675,050,0784,901,3855,069,6353,065,2021,915,3912,152,3771,651,3851,171,638871,341892,799988,124963,991714,127820,894886,046814,970712,021738,299855,931746,463751,411815,7062,057,2581,908,1852,787,9602,934,8282,969,84302,468,5762,610,9602,582,1252,450,0332,166,9882,010,1831,771,6051,629,1481,447,4951,389,689
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,115
58,030
153,000
7,481,158
6,933,818
7,068,733
5,869,009
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005,869,0097,068,7336,933,8187,481,158153,00058,03019,1150000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,115
58,030
153,000
7,481,158
6,933,818
7,068,733
5,869,009
8,935,639
8,061,330
7,856,256
8,265,730
9,405,592
10,269,717
9,071,674
8,428,008
9,670,224
8,899,263
8,430,525
8,538,065
8,621,019
8,546,922
8,161,013
7,799,036
7,799,0368,161,0138,546,9228,621,0198,538,0658,430,5258,899,2639,670,2248,428,0089,071,67410,269,7179,405,5928,265,7307,856,2568,061,3308,935,6395,869,0097,068,7336,933,8187,481,158153,00058,03019,1150000000000000000000000000000000000000000000000000000000
       Accounts payable 
558,895
598,113
658,934
810,444
857,682
892,470
985,686
1,552,810
1,031,366
1,067,798
0
1,447,982
1,495,918
1,564,827
1,070,565
996,591
371,669
329,197
355,573
396,994
411,295
332,548
431,046
477,214
411,329
340,702
474,696
418,803
425,061
355,682
494,610
613,886
806,570
775,153
1,406,068
1,681,791
1,682,713
1,601,134
2,274,772
2,565,328
2,917,947
2,432,108
2,952,136
3,571,700
3,433,948
2,929,081
2,794,790
2,926,094
2,707,941
2,588,091
2,660,821
2,609,322
2,737,556
3,054,427
2,879,478
10,551,237
11,350,647
11,969,454
10,821,218
11,945,528
13,126,617
13,592,957
11,868,463
11,088,462
13,699,625
14,070,937
13,550,759
12,749,177
13,874,428
14,722,281
13,596,306
13,391,541
15,154,889
14,960,831
14,544,608
15,012,139
16,148,633
15,685,868
15,685,86816,148,63315,012,13914,544,60814,960,83115,154,88913,391,54113,596,30614,722,28113,874,42812,749,17713,550,75914,070,93713,699,62511,088,46211,868,46313,592,95713,126,61711,945,52810,821,21811,969,45411,350,64710,551,2372,879,4783,054,4272,737,5562,609,3222,660,8212,588,0912,707,9412,926,0942,794,7902,929,0813,433,9483,571,7002,952,1362,432,1082,917,9472,565,3282,274,7721,601,1341,682,7131,681,7911,406,068775,153806,570613,886494,610355,682425,061418,803474,696340,702411,329477,214431,046332,548411,295396,994355,573329,197371,669996,5911,070,5651,564,8271,495,9181,447,98201,067,7981,031,3661,552,810985,686892,470857,682810,444658,934598,113558,895
       Other Current Liabilities 
320,002
376,443
316,975
400,621
458,271
565,398
479,208
23,758
708,145
512,579
0
550,230
460,992
266,646
369,073
408,612
184,855
178,939
182,546
317,657
267,662
316,103
325,554
381,427
368,485
334,557
434,737
484,901
333,697
370,731
524,951
899,831
1,180,640
1,057,769
1,581,634
2,775,765
2,689,825
2,939,292
2,684,745
3,120,126
2,892,483
3,068,889
2,834,790
3,699,286
3,051,134
3,269,735
3,605,278
3,944,202
3,957,045
4,809,142
4,923,995
4,855,285
4,727,069
5,171,620
4,955,047
3,295,826
5,457,287
5,055,694
1,723,897
2,492,387
178,038
6,802,179
6,118,354
4,315,153
5,571,354
3,782,780
6,620,145
3,440,344
7,082,307
5,379,551
6,800,425
7,186,604
6,788,318
9,096,805
8,052,297
4,543,628
443,242
695,880
695,880443,2424,543,6288,052,2979,096,8056,788,3187,186,6046,800,4255,379,5517,082,3073,440,3446,620,1453,782,7805,571,3544,315,1536,118,3546,802,179178,0382,492,3871,723,8975,055,6945,457,2873,295,8264,955,0475,171,6204,727,0694,855,2854,923,9954,809,1423,957,0453,944,2023,605,2783,269,7353,051,1343,699,2862,834,7903,068,8892,892,4833,120,1262,684,7452,939,2922,689,8252,775,7651,581,6341,057,7691,180,640899,831524,951370,731333,697484,901434,737334,557368,485381,427325,554316,103267,662317,657182,546178,939184,855408,612369,073266,646460,992550,2300512,579708,14523,758479,208565,398458,271400,621316,975376,443320,002
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,831,457
1,561,845
1,503,062
1,527,206
1,533,199
1,613,126
2,040,875
2,311,564
2,323,768
2,580,624
2,559,115
2,537,270
2,638,313
3,163,826
3,686,590
3,632,325
5,168,378
5,182,933
5,288,660
5,673,763
5,673,7635,288,6605,182,9335,168,3783,632,3253,686,5903,163,8262,638,3132,537,2702,559,1152,580,6242,323,7682,311,5642,040,8751,613,1261,533,1991,527,2061,503,0621,561,8451,831,4570000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-19,115
-58,030
-153,000
-7,481,158
-6,337,502
-6,514,567
-5,322,014
563,474
575,530
608,179
561,824
577,210
524,773
505,971
497,698
494,836
496,995
476,447
545,843
579,671
577,752
631,144
578,192
578,192631,144577,752579,671545,843476,447496,995494,836497,698505,971524,773577,210561,824608,179575,530563,474-5,322,014-6,514,567-6,337,502-7,481,158-153,000-58,030-19,1150000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,038,695
713,987
103,396
107,407
106,720
106,881
106,454
158,607
158,312
125,563
126,088
127,868
128,582
119,145
118,088
121,446
118,143
98,851
130,288
130,601
130,601130,28898,851118,143121,446118,088119,145128,582127,868126,088125,563158,312158,607106,454106,881106,720107,407103,396713,9871,038,6950000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,337
800
94,315
0
103,339
0
117,796
2,509
108,466
118,447
118,042
7,036
120,053
120,010
143,045
13,054
15,331
13,837
407,466
252,327
0
0
0
000252,327407,46613,83715,33113,054143,045120,010120,0537,036118,042118,447108,4662,509117,7960103,339094,31580076,3370000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
2,172,910
2,285,145
2,286,929
2,384,161
2,551,417
2,536,839
2,545,592
2,648,275
2,795,208
2,897,389
2,956,842
2,880,047
2,936,384
3,060,348
3,159,526
3,110,204
3,086,605
3,124,842
3,163,211
3,338,890
3,247,138
3,304,187
3,371,046
3,430,448
3,496,674
3,539,369
3,625,794
3,675,623
3,733,955
3,781,652
3,903,736
3,917,228
3,991,830
4,096,589
4,247,111
6,512,796
6,653,552
6,831,768
7,148,831
7,205,804
7,390,250
7,739,301
8,103,753
8,135,434
8,119,002
8,450,814
8,859,623
9,292,321
17,382,739
17,345,080
17,832,555
18,047,163
18,373,480
18,871,521
19,774,955
20,869,852
21,684,559
21,684,909
23,092,663
23,541,159
24,156,590
24,184,797
25,374,385
24,991,521
25,873,352
26,144,843
27,769,186
27,768,504
28,580,396
29,062,184
30,866,701
30,540,679
31,428,817
32,065,125
33,967,845
33,685,903
34,660,070
34,919,281
34,919,28134,660,07033,685,90333,967,84532,065,12531,428,81730,540,67930,866,70129,062,18428,580,39627,768,50427,769,18626,144,84325,873,35224,991,52125,374,38524,184,79724,156,59023,541,15923,092,66321,684,90921,684,55920,869,85219,774,95518,871,52118,373,48018,047,16317,832,55517,345,08017,382,7399,292,3218,859,6238,450,8148,119,0028,135,4348,103,7537,739,3017,390,2507,205,8047,148,8316,831,7686,653,5526,512,7964,247,1114,096,5893,991,8303,917,2283,903,7363,781,6523,733,9553,675,6233,625,7943,539,3693,496,6743,430,4483,371,0463,304,1873,247,1383,338,8903,163,2113,124,8423,086,6053,110,2043,159,5263,060,3482,936,3842,880,0472,956,8422,897,3892,795,2082,648,2752,545,5922,536,8392,551,4172,384,1612,286,9292,285,1452,172,910
   Common Stock
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
0
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
810,900
1,291,341
1,291,341
1,291,341
1,291,341
1,291,341
1,291,341
1,291,341
1,291,341
1,291,079
1,291,079
1,291,079
1,291,079
1,291,079
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
1,625,791
0
0
0
0001,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,625,7911,291,0791,291,0791,291,0791,291,0791,291,0791,291,3411,291,3411,291,3411,291,3411,291,3411,291,3411,291,3411,291,341810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900810,9000810,900810,900810,900810,900810,900810,900810,900810,900810,900810,900
   Retained Earnings 
532
107,505
25,265
118,878
145,348
130,365
73,131
166,278
215,903
219,869
0
915,926
972,264
1,088,706
1,202,323
1,154,776
1,132,524
1,170,651
1,208,446
756,872
1,291,334
1,349,204
1,417,499
1,477,436
1,536,007
1,575,749
1,662,729
1,714,825
1,775,199
1,822,735
1,944,886
1,958,730
2,034,270
2,136,924
2,290,109
2,738,999
2,880,028
3,054,334
3,372,028
3,430,985
3,614,168
3,949,798
4,314,925
4,363,246
4,473,538
4,814,033
5,223,351
5,645,839
5,870,455
5,834,328
6,318,990
6,537,247
6,864,758
7,440,759
8,345,928
9,372,531
10,192,825
10,194,511
10,232,620
10,684,002
11,295,962
12,694,061
13,877,924
13,500,739
14,395,538
14,651,714
16,279,135
16,279,420
17,088,781
17,496,916
19,302,557
18,969,994
19,854,365
20,346,520
22,255,121
19,883,302
20,863,305
20,959,331
20,959,33120,863,30519,883,30222,255,12120,346,52019,854,36518,969,99419,302,55717,496,91617,088,78116,279,42016,279,13514,651,71414,395,53813,500,73913,877,92412,694,06111,295,96210,684,00210,232,62010,194,51110,192,8259,372,5318,345,9287,440,7596,864,7586,537,2476,318,9905,834,3285,870,4555,645,8395,223,3514,814,0334,473,5384,363,2464,314,9253,949,7983,614,1683,430,9853,372,0283,054,3342,880,0282,738,9992,290,1092,136,9242,034,2701,958,7301,944,8861,822,7351,775,1991,714,8251,662,7291,575,7491,536,0071,477,4361,417,4991,349,2041,291,334756,8721,208,4461,170,6511,132,5241,154,7761,202,3231,088,706972,264915,9260219,869215,903166,27873,131130,365145,348118,87825,265107,505532
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,648
1,423
-477
433
-2,453
1,018
-139
5,586
-93
-13,061
-17,673
-20,751
-21,718
-19,187
-17,476
-18,600
-12,111
-8,343
-12,901
-18,781
0
0
0
000-18,781-12,901-8,343-12,111-18,600-17,476-19,187-21,718-20,751-17,673-13,061-935,586-1391,018-2,453433-4771,423-3,6480000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue75,515,404
Cost of Revenue-61,328,110
Gross Profit14,187,29414,187,294
 
Operating Income (+$)
Gross Profit14,187,294
Operating Expense-70,642,909
Operating Income4,872,495-56,455,615
 
Operating Expense (+$)
Research Development782,144
Selling General Administrative6,709,364
Selling And Marketing Expenses0
Operating Expense70,642,9097,491,508
 
Net Interest Income (+$)
Interest Income486,336
Interest Expense-446,192
Other Finance Cost-20,584
Net Interest Income19,561
 
Pretax Income (+$)
Operating Income4,872,495
Net Interest Income19,561
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,110,4984,872,495
EBIT - interestExpense = -446,192
4,055,679
4,501,870
Interest Expense446,192
Earnings Before Interest and Taxes (EBIT)05,556,690
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax5,110,498
Tax Provision-851,170
Net Income From Continuing Ops4,259,3284,259,328
Net Income4,055,679
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-19,561
 

Technical Analysis of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The general trend of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 29.08 < 30.30 < 30.30.

The bearish price targets are: 26.50 > 26.50 > 24.85.

Tweet this
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current macd is -0.15517483.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current adx is 21.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current sar is 29.74.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current rsi is 41.47. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Relative Strength Index (RSI) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Stochastic Oscillator ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current cci is -106.66341225.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Commodity Channel Index (CCI) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current cmo is -26.4163973.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current willr is -79.32692308.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Williams %R ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current atr is 0.48758462.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Average True Range (ATR) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current obv is 235,593,517.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily On-Balance Volume (OBV) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. The current mfi is 32.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Money Flow Index (MFI) ChartGuangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.469
Ma 20Greater thanMa 5029.487
Ma 50Greater thanMa 10028.852
Ma 100Greater thanMa 20029.068
OpenGreater thanClose28.540
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

I send you an email if I find something interesting about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

Receive notifications about Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd in your mailbox!